References
- Rodda BE. Bioequivalence of solid oral dosage forms. A Presentation to U.S. Food and Drug Administration Hearing on Bioequivalence of Solid Oral Dosage Forms, Pharmaceutical Manufacturers Association. September 29—October 1, Section III, 1986, p. 12–5.
- Metzler CM, Huang DC. Statistical methods for bioavailability and bioequivalence. Clin Res Pr Drug Regul Aff 1983; 1(2): 109–32.
- Chow SC, Tse SK. Outlier detection in bioavailability/bioequivalence studies. Stat Med 1990; 9(5): 549–58.
- Bolton S. Outliers—examples and opinions. Presented at bioavailability/bioequivalence: Pharmacokinetic and Statistical Considerations sponsored by Drug Information Association, Bethesda, Maryland, August, 1991.
- Liu JP, Weng CS. Detection of outlying data in bioavailability/bioequivalence studies. Stat Med 1991; 10(9): 1375–89.
- Wang W, Chow SC. Examining outlying subjects and outlying records in bioequivalence trials. J Biopharm Stat 2003; 13(1): 43–56.
- Kayaalp SO. Klinik Farmakolojinin Esasları ve Temel Düzenlemeler. 2. Baskı, Ankara: Hacettepe Taş Kitapçılık; 2001. p. 305–47.
- Food and Drug Administration (FDA). Guidance for industry: Bioavailability and bioequivalence studies for orally administered drug products-general considerations. U.S. Department of Health and Human Services, Center for Drug Evaluation and Research, Rockville, Maryland, March, 2003.
- Karasoy D, Gündüz İ. Statistical methods in bioequivalence studies and an application. Turkiye Klinikleri J Med Sci 2008; 28(5): 653–62. (Turkish).
- Anderson S, Hauck WW. Consideration of individual bioequivalence. J Pharmacokinet Biopharm 1990; 18(3): 259–73.
- Chen ML, Patnaik R, Hauck WW, Schuirmann DJ, Hyslop T, Williams R. An individual bioequivalence criterion: Regulatory considerations. Stat Med 2000; 19(20): 2821–42.
- Barnett V, Lewis T (editors). Outliers in statistical data. Third ed., John Wiley & Sons; 1994. p. 31–52.
- Ki FYC, Liu JP, Wang W, Chou SC. The impact of outlying subjects on decision of bioequivalence. J Biopharm Stat 1995; 5(1): 71–94.
- Beckman RJ, Cook RD. Outlier…s (with discussion). Technometrics 1983; 25(2): 119–49.
- Cook RD, Weisberg S (editors). Residuals and influence in regression. New York and London: Chapman and Hall, 1982, p. 183–205.
- Ramsay T, Elkum N. A comparison of four different methods for outlier detection in bioequivalence studies. J Biopharm Stat 2005; 15(1): 43–52.